A Continued Access Protocol to Provide Xolair to Patients With Severe Allergic Asthma
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Asthma
Related studies linked through entity extraction aliases.
An Extension Study of Xolair in Moderate to Severe, Persistent Asthma Patients Who Completed Study Q2143g
- Status
- COMPLETED
- Phase
- PHASE3
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
- Status
- COMPLETED
- Phase
- PHASE4
Study Of Asthma In Patients Of African Descent
- Status
- COMPLETED
- Phase
- PHASE4
A Prospective, Randomized, Double-Blind Study of the Efficacy of Omalizumab (Xolair) in Atopic Asthmatics With Good Lung Capacity Who Remain Difficult to Treat (EXACT)
- Status
- COMPLETED
- Phase
- PHASE4
Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma
- Status
- COMPLETED
- Phase
- PHASE2
Complementary and Alternative Medicine Use in Low-Income African American and Caucasian Adults With Asthma
- Status
- COMPLETED
- Phase
- N/A
Intervention for Improving Asthma Care for Minority Children in Head Start
- Status
- COMPLETED
- Phase
- NA
Evaluation of Two Doses of QVAR by Breath Operated and Metered Dose Inhalers in Asthmatic Children
- Status
- COMPLETED
- Phase
- PHASE3
Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288)
- Status
- COMPLETED
- Phase
- PHASE3
Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
Genetic Studies in Difficult to Treat Asthma: TENOR
- Status
- COMPLETED
- Phase
- N/A
Genetic Risk Factors for Severe Asthma
- Status
- COMPLETED
- Phase
- N/A
Maternal Fatty Acids, Child Obesity, and Asthma Immunity
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma
- Status
- COMPLETED
- Phase
- PHASE3
Exhaled Breath Condensate as a Measure of Airway Inflammation in Children With Asthma
- Status
- COMPLETED
- Phase
- N/A
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma
- Status
- COMPLETED
- Phase
- PHASE3
Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma
- Status
- COMPLETED
- Phase
- PHASE3
Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma
- Status
- COMPLETED
- Phase
- PHASE3